AG
Andrew Gengos bought $90K of IMRX stock
Andrew Gengos, Chief Financial Officer of Immuneering Corp (IMRX), bought 25,000 shares of IMRX stock worth $90K, per an SEC Form 4 filed Nov 16, 2026.
It was an open-market purchase.
The trade happened on Nov 13, 2026, 3 days before it was made public.
IMRX has moved -7.0% since the trade date, from $3.71 to $3.45 (Nov 19, 2026 close).
- Traded
- Nov 13, 2026
- Disclosed
- Nov 16, 2026
- Filing delay
- 3 days
- Price since
- -7.0%
- Role
- Chief Financial Officer
- Source
- SEC Form 4